Garitaonaindia, Y., Petersen, S. K.
, Guldbrandt, L. M., Borch, T. H., Ruhlmann, C. H.
, Friis, R. B., Luczak, A. A., Bastholt, L.
, Schmidt, H., Svane, I. M., Ellebaek, E. & Donia, M. (2026).
Real-World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond.
International Journal of Cancer. Advance online publication.
https://doi.org/10.1002/ijc.70520Van Eldere, J., Aiuti, A., Lluesma, S. M.
, Møller, B. K., Laursen, B. E., Lebbe, C., Piris, A., Carmona, J., Goldsobel, G., Kintscher, U., Vandenberghe, P., Huys, I., Geers, B., Benjamin, R., Potter, V., Bonini, C., Ciceri, F., Martino, G., Debets, R. ... Künkele, A. (2026).
A roadmap for supporting the development of advanced therapy medicinal products in a European framework.
The Lancet Regional Health - Europe,
66, Article 101688.
https://doi.org/10.1016/j.lanepe.2026.101688Federico, A., Schmitt-Hoffner, F., Fonseca, A., Geisemeyer, N., Bruckner, K., Mauermann, M., Sill, M., Stichel, D., Sturm, D., Schüller, U., Tauziede-Espariat, A., Varlet, P., Capper, D., Abdullaev, Z., Schrimpf, D., Selt, F., Williamson, L., Donson, A. M., Antonelli, M. ... Kool, M. (2026).
Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies.
Neuro-Oncology,
28(4), 1005-1019.
https://doi.org/10.1093/neuonc/noaf283von Heymann, A.
, Nissen, E. R., Ågård, A. S., Egerod, I., Kokla, M.
, Farver-Vestergaard, I., Prigerson, H. G., Lichtenthal, W. G., Johansen, C.
, Zachariae, R. & O'Toole, M. S. (2026).
Tele-delivered psychotherapeutic intervention for family members of patients in intensive care: a nonrandomized pilot study.
Annals of the American Thoracic Society,
23(5), 782-790.
https://doi.org/10.1093/annalsats/aaoag015Deng, B., Head, R., Draaisma, K., Hoeben, A.
, Lukacova, S., Lombardi, G., Leenstra, S., Hanse, M., Fleischeuer, R. E. M., Watts, C., Angelopoulos, N., Gorlia, T., Bours, V., van den Bent, M. J., Robe, P. A., Hoogstrate, Y. & French, P. J. (2026).
Epigenetic evolution of isocitrate dehydrogenase-wildtype glioblastomas.
Neuro-Oncology,
28(4), 1053-1064.
https://doi.org/10.1093/neuonc/noaf298Crestani, A., Merlot, B., Chanavaz Lacheray, I., Dennis, T., Goualard, P. H.
& Roman, H. (2026).
ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts.
BMJ Open,
16(4), e112291.
https://doi.org/10.1136/bmjopen-2025-112291van Koppen, A., Inia, J. A., Gonzalez-Villalobos, R. A., Smits, A. M., Nawrocki, A. R., Hinke, S. A., Attema, J., de Ruiter, C., Nguyen, T. Q., Dendooven, A., Bajema, I., van Goor, H., van Veen, T. A. B., van Ham, W. B., Eichinger, F.
, Elsborg, S. H., Mutsaers, H. A. M., Pieterman, E. J., Menke, A. L. ... Stoop, R. (2026).
A novel mouse model for cardiovascular-kidney-metabolic syndrome: Bridging metabolic, renal and cardiac dysfunction.
Molecular Metabolism,
108, Article 102368.
https://doi.org/10.1016/j.molmet.2026.102368Ipsen, J. A., Viberg, B., Holsgaard-Larsen, A., Abrahamsen, C.
, Gundtoft, P. H., Costa, M., Mikkelsen, S. S. & Hróbjartsson, A. (2026).
Lack of device producer assessments and transparency thwarts environmental outcome reporting in a large clinical trial.
Journal of Clinical Epidemiology,
195, Article 112265.
https://doi.org/10.1016/j.jclinepi.2026.112265Bezerra, N. M. B., Lisboa, L. L., Vasconcelos, R. A. L.
, Krogh, K., Gomes, C. M. & Calado, A. A. (2026).
Cultural adaptation and validation for Brazilian portuguese of the MENTOR tool: monitoring the efficacy of neurogenic bowel treatment.
Spinal Cord. Advance online publication.
https://doi.org/10.1038/s41393-026-01203-3